In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: Potential mediating mechanisms and sex differences

Brain, Behavior, and Immunity

Volumn 26, Issue 6, 2012, Pages 996-1005

  Shaashua, L ^a   Sominsky, L ^a,b   Levi, B ^a   Sorski, L ^a   Reznick, M ^a   Page, G G ^c   Ben Eliyahu, S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Acute; Chronic; In vivo; Induced production; Interleukin 12; Sex differences; Social confrontation; Stress; Surgery

Indexed keywords

ADRENALIN; CORTICOSTERONE; CYTOKINE; INTERLEUKIN 12; PROSTAGLANDIN E2;

ACUTE STRESS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MALE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SOCIAL BEHAVIOR;

ANIMALS; CORTICOSTERONE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPINEPHRINE; FEMALE; HOUSING, ANIMAL; INTERLEUKIN-12; LAPAROTOMY; MALE; OLIGODEOXYRIBONUCLEOTIDES; RATS; RATS, INBRED F344; RATS, LONG-EVANS; RESTRAINT, PHYSICAL; SEX CHARACTERISTICS; SOCIAL ENVIRONMENT; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84863867759     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.05.012     Document Type: Article

References (46)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383(6603):787-793.
2. Araneo B.A., Dowell T., Diegel M., Daynes R.A. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991, 78(3):688-699.
3. Bartal I., Melamed R., Greenfeld K., Atzil S., Glasner A., Domankevich V., Naor R., Beilin B., Yardeni I.Z., Ben-Eliyahu S. Immune perturbations in patients along the perioperative period: alterations in cell surface markers and leukocyte subtypes before and after surgery. Brain Behav. Immun. 2010, 24(3):376-386.
4. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 2003, 17(Suppl 1):S27-36.
5. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. NeuroImmunoModulation 2000, 8(3):154-164.
6. Colacchio T.A., Yeager M.P., Hildebrandt L.W. Perioperative immunomodulation in cancer surgery. Am. J. Surg. 1994, 167(1):174-179.
7. Curtin N.M., Boyle N.T., Mills K.H., Connor T.J. Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav. Immun. 2009, 23(4):535-547.
8. Curtsinger J.M., Lins D.C., Mescher M.F. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 2003, 197(9):1141-1151.
9. 4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 1998, 160(5):2231-2237.
10. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians 1996, 108(5):374-381.
11. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 2008, 8(9):737-744.
12. Gaillard R.C., Spinedi E. Sex- and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphism. Domest. Anim. Endocrinol. 1998, 15(5):345-352.
13. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 1997, 158(1):446-451.
14. Glasner A., Avraham R., Rosenne E., Benish M., Zmora O., Shemer S., Meiboom H., Ben-Eliyahu S. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 2010, 184(5):2449-2457.
15. Greenfeld K., Avraham R., Benish M., Goldfarb Y., Rosenne E., Shapira Y., Rudich T., Ben-Eliyahu S. Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav. Immun. 2007, 21(4):503-513.
16. Gwosdow A.R., O'Connell N.A., Spencer J.A., Kumar M.S., Agarwal R.K., Bode H.H., Abou-Samra A.B. Interleukin-1-induced corticosterone release occurs by an adrenergic mechanism from rat adrenal gland. Am. J. Physiol. 1992, 263(3 Pt 1):E461-466.
17. Haim S., Shakhar G., Rossene E., Taylor A.N., Ben-Eliyahu S. Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females. J. Endocrinol. Invest. 2003, 26(10):1013-1022.
18. Kanegane C., Sgadari C., Kanegane H., Teruya-Feldstein J., Yao L., Gupta G., Farber J.M., Liao F., Liu L., Tosato G. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. J. Leukoc. Biol. 1998, 64(3):384-392.
19. Kiecolt-Glaser J.K., Glaser R., Shuttleworth E.C., Dyer C.S., Ogrocki P., Speicher C.E. Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom. Med. 1987, 49(5):523-535.
20. Kitay J.I. Sex differences in adrenal cortical secretion in the rat. Endocrinology 1961, 68:818-824.
21. Kubin M., Kamoun M., Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 1994, 180(1):211-222.
22. Kurabekova R.M., Mataradze G.D., Rozen V.B. Mechanisms of sex differentiation of the level of corticosteroid-binding globulin in rats. Probl. Endokrinol. (Mosk.) 1988, 34(6):66-70.
23. Leibowitz S.F., Sladek C., Spencer L., Tempel D. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res. Bull. 1988, 21(6):905-912.
24. Levi B., Benish M., Goldfarb Y., Sorski L., Melamed R., Rosenne E., Ben-Eliyahu S. Continuous stress disrupts immunostimulatory effects of IL-12. Brain Behav. Immun. 2011, 25(4):727-735.
25. Metzger D.W., McNutt R.M., Collins J.T., Buchanan J.M., Van Cleave V.H., Dunnick W.A. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur. J. Immunol. 1997, 27(8):1958-1965.
26. Nguyen L.T., Ramanathan M., Weinstock-Guttman B., Baier M., Brownscheidle C., Jacobs L.D. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J. Neurol. Sci. 2003, 209(1-2):93-99.
27. O'Connell N.A., Kumar A., Chatzipanteli K., Mohan A., Agarwal R.K., Head C., Bornstein S.R., Abou-Samra A.B., Gwosdow A.R. Interleukin-1 regulates corticosterone secretion from the rat adrenal gland through a catecholamine-dependent and prostaglandin E2-independent mechanism. Endocrinology 1994, 135(1):460-467.
28. Ogawa K., Hirai M., Katsube T., Murayama M., Hamaguchi K., Shimakawa T., Naritake Y., Hosokawa T., Kajiwara T. Suppression of cellular immunity by surgical stress. Surgery 2000, 127(3):329-336.
29. Page G.G., Ben-Eliyahu S., Liebeskind J.C. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immun. 1994, 8(3):241-250.
30. Panina-Bordignon P., Mazzeo D., Lucia P.D., D'Ambrosio D., Lang R., Fabbri L., Self C., Sinigaglia F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 1997, 100(6):1513-1519.
31. Perussia B., Chan S.H., D'Andrea A., Tsuji K., Santoli D., Pospisil M., Young D., Wolf S.F., Trinchieri G. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J. Immunol. 1992, 149(11):3495-3502.
32. Saoudi A., Kuhn J., Huygen K., de Kozak Y., Velu T., Goldman M., Druet P., Bellon B. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 1993, 23(12):3096-3103.
33. Saul A.N., Oberyszyn T.M., Daugherty C., Kusewitt D., Jones S., Jewell S., Malarkey W.B., Lehman A., Lemeshow S., Dhabhar F.S. Chronic stress and susceptibility to skin cancer. J. Natl Cancer Inst. 2005, 97(23):1760-1767.
34. Scott B., Liblau R., Degermann S., Marconi L.A., Ogata L., Caton A.J., McDevitt H.O., Lo D. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994, 1(1):73-83.
35. Stefanski V., Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol. Behav. 1996, 60(1):277-282.
36. Stefanski V., Peschel A., Reber S. Social stress affects migration of blood T cells into lymphoid organs. J. Neuroimmunol. 2003, 138(1-2):17-24.
37. Stern A.S., Magram J., Presky D.H. Interleukin-12 an integral cytokine in the immune response. Life Sci. 1996, 58(8):639-654.
38. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., Jennings N.B., Armaiz-Pena G., Bankson J.A., Ravoori M., Merritt W.M., Lin Y.G., Mangala L.S., Kim T.J., Coleman R.L., Landen C.N., Li Y., Felix E., Sanguino A.M., Newman R.A., Lloyd M., Gershenson D.M., Kundra V., Lopez-Berestein G., Lutgendorf S.K., Cole S.W., Sood A.K. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 2006, 12(8):939-944.
39. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3(2):133-146.
40. Trinchieri G., Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol. Today 1994, 15(10):460-463.
41. van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995, 181(2):775-779.
42. Weiner G.J. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J. Leukoc. Biol. 2000, 68(4):455-463.
43. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2(9):777-780.
44. Wynn D.R., Rodriguez M., O'Fallon W.M., Kurland L.T. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990, 40(5):780-786.
45. Yakar I., Melamed R., Shakhar G., Shakhar K., Rosenne E., Abudarham N., Page G.G., Ben-Eliyahu S. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol. 2003, 10(4):469-479.
46. 4+ T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J. Immunol. 2002, 169(7):3637-3643.